No Data
No Data
Lanxiao Technology (300487): Q1 performance is in line with expectations, and the biotechnology sector continues to grow rapidly
Guide to this report: The company's 24Q1 performance is in line with expectations. Businesses such as biotechnology, water treatment, and environmental protection are developing rapidly and maintaining an “increase” rating. Investment Essentials: Maintaining an “Overweight” rating. The company's revenue and profit grew rapidly, and we maintained 24-
Huaan Securities released a research report on April 27 stating that it gave Lanxiao Technology (300487.SZ) a purchase rating. The main reasons for the rating include: 1) the main business continues to improve, and salt lake lithium extraction has contrib
Huaan Securities released a research report on April 27 stating that it gave Lanxiao Technology (300487.SZ) a purchase rating. The main reasons for the rating include: 1) the main business continues to improve, and salt lake lithium extraction has contributed significantly; 2) cost control has been strengthened and the financial situation is steady; 3) the biotechnology sector is booming, solid phase carriers drive high revenue growth; 4) outstanding R&D capabilities, the stock market share continues to increase, and overseas markets are further penetrated. (Mainichi Keizai Shimbun)
Lanxiao Technology (300487): Performance increased year-on-year, platform-based companies are steady and far-reaching
Incident: The company recently released its 2023 annual report and 2024 quarterly report. In 2023, it achieved revenue of 2,489 billion yuan, +29.62% year-on-year, and realized net profit of 717 million yuan, +33.35% year-on-year.
Shanghai Securities released a research report on April 24 stating that it gave Lanxiao Technology (300487.SZ) a purchase rating. The main reasons for the rating include: 1) Life science and other businesses continue to maintain high growth, boosting the
Shanghai Securities released a research report on April 24 stating that it gave Lanxiao Technology (300487.SZ) a purchase rating. The main reasons for the rating include: 1) Life science and other businesses continue to maintain high growth, boosting the company's profitability; 2) major lithium extraction projects in Salt Lake are being delivered one after another, and the chassis business continues to grow steadily; 3) R&D-driven development, and the competitiveness of the company's products continues to improve; 4) demand falls short of expectations, raw material prices fluctuate, customer development falls short of expectations, and the progress of the project falls short of expectations. (Mainichi Keizai Shimbun)
Guohai Securities released a research report on April 23 stating that it gave Lanxiao Technology (300487.SZ) a purchase rating. The main reasons for the rating include: 1) rapid development in various fields, with the company's performance improving year
Guohai Securities released a research report on April 23 stating that it gave Lanxiao Technology (300487.SZ) a purchase rating. The main reasons for the rating include: 1) rapid development in various fields, with the company's performance improving year on year; 2) year-on-year performance growth in the first quarter, which is expected to continue to improve in annual performance; 3) solid phase synthesis carriers, soft and hard rubber lead life science growth, and water treatment is expected to continue to increase; 4) Salt Lake lithium production continues to increase development efforts, and the resource chain for other metals such as nickel continues to expand. (Mainichi Keizai Shimbun)
Lanxiao Technology (300487): R&D innovation drives more growth in performance and continuous improvement in brand value
Incident: The company released its 2023 annual report and 2024 quarterly report. In 2023, it achieved operating income of 2,489 billion yuan, +29.62% year-on-year; realized net profit/deducted non-net profit of 717/723 million yuan
No Data